Cancer Council Australia is a partner in Cancer Australia’s Priority-driven Collaborative Cancer Research Scheme, which funds cancer research in identified priority areas. The scheme brings together government and other funders to collaboratively fund cancer research in Australia, improving coordination and maximising the impact of our investments.
As one of the scheme’s funding partners, our priority is research addressing inequalities in cancer care and outcomes. This includes variations related to community, sociodemographic, economic, cultural, racial or other factors.
In December 2015 Cancer Australia announced the successful applicants for grants for projects commencing in 2016. Cancer Council Australia awarded a priority-driven grant for 2016 to Professor Danielle Mazza at Monash University.
Professor Mazza’s research project aims to uncover why Australians from culturally and linguistically diverse (CALD) backgrounds have poorer lung cancer outcomes (higher mortality rates) by comparing their treatment pathways to those of Anglo-Australian patients. The grant to Professor Mazza was $430,000 over three years.
Despite being the leading cause of cancer death in Australia, lung cancer has traditionally attracted less research funding. This study funded by Cancer Council is the first of its kind in Australia and will help identify inequities in the health system that can be addressed to improve outcomes for CALD patients.
For more information
This page was last updated on: Friday, October 21, 2016